4.4 Article

Diagnosis and management of anastomotic leaks after Ivor Lewis esophagectomy: a single-center experience

Journal

LANGENBECKS ARCHIVES OF SURGERY
Volume 408, Issue 1, Pages -

Publisher

SPRINGER
DOI: 10.1007/s00423-023-03121-x

Keywords

Esophagectomy; Esophageal surgery; Anastomotic leaks

Categories

Ask authors/readers for more resources

The purpose of this study was to assess the incidence, diagnostic approach, and management of esophageal anastomotic leaks (ALs) after Ivor Lewis esophagectomy. The study included 145 patients who underwent the surgery from August 2016 to July 2022. Out of these, 10 patients (6.9%) developed an AL, which was diagnosed using various methods such as enteric contents in wound drains, endoscopy, CT, and contrast esophagogram.
Purpose Esophageal anastomotic leaks (ALs) after esophagectomy are a common and serious complication. The incidence, diagnostic approach, and management have changed over time. We described the diagnosis and management of patients who developed an esophageal AL after an Ivor Lewis esophagectomy at our center.Methods After IRB approval, we queried our prospectively maintained database for patients who developed an esophageal AL after esophagectomy from August 2016 through July 2022. Data pertaining to demographics, comorbidities, surgical and oncological characteristics, and clinical course were extracted and analyzed.Results During the study period, 145 patients underwent an Ivor Lewis esophagectomy; 10 (6.9%) developed an AL, diagnosed a median of 7.5 days after surgery, and detected by enteric contents in wound drains (n = 3), endoscopy (n = 3), CT (n = 2), and contrast esophagogram (n = 2). Nine patients (90%) had an increasing white blood cell count and additional signs of sepsis. One asymptomatic patient was identified by contrast esophagography. All patients received enteral nutritional support, intravenous antibiotics, and antifungals. Primary treatment of ALs included endoscopic placement of a self-expanding metal stent (SEMS; n = 6), surgery (n = 2), and SEMS with endoluminal vacuum therapy (n = 2). One patient required surgery after SEMS placement. The median length of ICU and total hospital stays were 11.5 and 22.5 days, respectively. There was no 30-day mortality.Conclusion The incidence of esophageal ALs at our center is similar to that of other high-volume centers. Most ALs can be managed without surgery; however, ALs remain a significant source of postoperative morbidity despite clinical advancements that have improved mortality.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available